JP2024511479A5 - - Google Patents
Info
- Publication number
- JP2024511479A5 JP2024511479A5 JP2023559015A JP2023559015A JP2024511479A5 JP 2024511479 A5 JP2024511479 A5 JP 2024511479A5 JP 2023559015 A JP2023559015 A JP 2023559015A JP 2023559015 A JP2023559015 A JP 2023559015A JP 2024511479 A5 JP2024511479 A5 JP 2024511479A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- domain containing
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163166793P | 2021-03-26 | 2021-03-26 | |
| US63/166,793 | 2021-03-26 | ||
| PCT/US2022/022041 WO2022204568A1 (en) | 2021-03-26 | 2022-03-25 | Maytansine-antibody conjugates and methods of using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511479A JP2024511479A (ja) | 2024-03-13 |
| JP2024511479A5 true JP2024511479A5 (https=) | 2025-04-01 |
Family
ID=83397950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023559015A Pending JP2024511479A (ja) | 2021-03-26 | 2022-03-25 | メイタンシン抗体コンジュゲートおよびそれを使用する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240156978A1 (https=) |
| EP (1) | EP4313009A4 (https=) |
| JP (1) | JP2024511479A (https=) |
| CN (1) | CN117412741A (https=) |
| AU (1) | AU2022245388A1 (https=) |
| CA (1) | CA3213065A1 (https=) |
| WO (1) | WO2022204568A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX384984B (es) * | 2013-10-10 | 2025-03-14 | Beth Israel Deaconess Medical Ct Inc | Proteinas de union del miembro 1 de la familia de transmembrana 4 l-seis (tm4sf1) y metodos de uso de las mismas. |
| CN115504924A (zh) * | 2013-11-27 | 2022-12-23 | 雷德伍德生物科技股份有限公司 | 肼基-吡咯并化合物及用于生成缀合物的方法 |
| CN109265546B (zh) * | 2017-07-17 | 2022-05-24 | 同济大学苏州研究院 | 用于治疗癌症的新靶标 |
| MX2020002241A (es) * | 2017-08-28 | 2020-09-03 | Angiex Inc | Anticuerpos anti-tm4sf y métodos de uso de los mismos. |
| MX2021010254A (es) * | 2019-02-27 | 2021-09-21 | Angiex Inc | Conjugados de anticuerpo-farmaco que comprenden anticuerpos anti-tm4sf1 y metodos de uso de los mismos. |
-
2022
- 2022-03-25 JP JP2023559015A patent/JP2024511479A/ja active Pending
- 2022-03-25 CN CN202280038264.9A patent/CN117412741A/zh active Pending
- 2022-03-25 AU AU2022245388A patent/AU2022245388A1/en active Pending
- 2022-03-25 WO PCT/US2022/022041 patent/WO2022204568A1/en not_active Ceased
- 2022-03-25 CA CA3213065A patent/CA3213065A1/en active Pending
- 2022-03-25 EP EP22776761.3A patent/EP4313009A4/en active Pending
-
2023
- 2023-09-25 US US18/473,517 patent/US20240156978A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022522007A5 (https=) | ||
| JP7585230B2 (ja) | バイパラトピックＦＲ－α抗体及びイムノコンジュゲート | |
| US11517625B2 (en) | Antibody-drug-conjugate and its use for the treatment of cancer | |
| JP7467610B2 (ja) | カンプトテシン誘導体及びその複合体 | |
| JP6258523B2 (ja) | Ｉｇｆ−１ｒ抗体−薬物複合体および癌の処置のためのその使用 | |
| JP2017518304A (ja) | 抗体−薬物コンジュゲート、それらの製造、及びそれらの治療用途 | |
| TWI879780B (zh) | 抗組織因子抗體-藥物結合物及相關方法 | |
| KR20180104157A (ko) | 인간화 항-cd3 항체, 접합체 및 이의 용도 | |
| JP2017503777A (ja) | 細胞障害性ペプチドおよびその抱合体 | |
| CN102753577A (zh) | 双特异性抗-vegf/抗-ang-2抗体 | |
| RU2012112067A (ru) | Терапевтические dll4-связующие белки | |
| US20260042847A1 (en) | Cysteine engineered antibody constructs, conjugates and methods of use | |
| JP2025061007A5 (https=) | ||
| JP2024511479A5 (https=) | ||
| CA3248952A1 (en) | PHARMACEUTICAL COMPOSITION COMPRISING AN ANTI-CD79B ANTIBODY-DRUG CONJUGATE AND ITS USE | |
| RU2824761C2 (ru) | Биофармацевтические композиции и связанные с ними способы | |
| WO2023222108A1 (zh) | 抗体-药物偶联物的制备方法 | |
| JP2021517133A5 (https=) | ||
| EA052782B1 (ru) | Конъюгаты антитело к тканевому фактору-лекарственное средство и связанные способы | |
| WO2026035986A1 (en) | Humanized anti-cdh17 antibodies and use of the same | |
| WO2026069278A1 (en) | Anti-cd123 antibodies and neodegrader conjugates | |
| RU2023135796A (ru) | Биспецифическая связывающая молекула, которая связывается с vegf и ang2, и ее применение | |
| RU2023100251A (ru) | Антитело против клаудина 18.2 и его конъюгат антитело-лекарственное средство |